UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006877 |
|---|---|
| Receipt number | R000008105 |
| Scientific Title | Phase II study of XELIRI with bevacizumab as second-line therapy for metastatic colorectal cancer -Beyond Progression Disease of capecitabine and bebacizumab - |
| Date of disclosure of the study information | 2011/12/12 |
| Last modified on | 2020/07/28 11:20:42 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/12/12 14:50:02 | ||
| 2 | Update | 2013/12/12 14:42:44 | TEL |
|
| 3 | Update | 2014/06/13 14:33:58 | Email |
|
| 4 | Update | 2015/08/12 14:37:26 | Recruitment status |
|
| 5 | Update | 2020/07/28 11:20:42 | Recruitment status Date of IRB Last follow-up date |
